1. Home
  2. BRID vs TLSA Comparison

BRID vs TLSA Comparison

Compare BRID & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRID
  • TLSA
  • Stock Information
  • Founded
  • BRID 1932
  • TLSA 2013
  • Country
  • BRID United States
  • TLSA United Kingdom
  • Employees
  • BRID N/A
  • TLSA N/A
  • Industry
  • BRID Specialty Foods
  • TLSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • BRID Consumer Staples
  • TLSA Health Care
  • Exchange
  • BRID Nasdaq
  • TLSA Nasdaq
  • Market Cap
  • BRID 70.3M
  • TLSA 187.0M
  • IPO Year
  • BRID N/A
  • TLSA 2000
  • Fundamental
  • Price
  • BRID $7.80
  • TLSA $1.68
  • Analyst Decision
  • BRID
  • TLSA
  • Analyst Count
  • BRID 0
  • TLSA 0
  • Target Price
  • BRID N/A
  • TLSA N/A
  • AVG Volume (30 Days)
  • BRID 4.6K
  • TLSA 334.2K
  • Earning Date
  • BRID 08-22-2025
  • TLSA 05-06-2025
  • Dividend Yield
  • BRID N/A
  • TLSA N/A
  • EPS Growth
  • BRID N/A
  • TLSA N/A
  • EPS
  • BRID N/A
  • TLSA N/A
  • Revenue
  • BRID $224,673,000.00
  • TLSA N/A
  • Revenue This Year
  • BRID N/A
  • TLSA N/A
  • Revenue Next Year
  • BRID N/A
  • TLSA N/A
  • P/E Ratio
  • BRID N/A
  • TLSA N/A
  • Revenue Growth
  • BRID N/A
  • TLSA N/A
  • 52 Week Low
  • BRID $7.35
  • TLSA $0.63
  • 52 Week High
  • BRID $10.83
  • TLSA $2.60
  • Technical
  • Relative Strength Index (RSI)
  • BRID 51.85
  • TLSA 44.00
  • Support Level
  • BRID N/A
  • TLSA $1.63
  • Resistance Level
  • BRID $8.15
  • TLSA $1.88
  • Average True Range (ATR)
  • BRID 0.23
  • TLSA 0.15
  • MACD
  • BRID -0.27
  • TLSA -0.01
  • Stochastic Oscillator
  • BRID 95.64
  • TLSA 43.59

About BRID Bridgford Foods Corporation

Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are; the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: